RIGEL PHARMACEUTICALS INC (RIGL)       1.15  -0.01 (-0.86%)

1.15  -0.01 (-0.86%)

US7665596034 - Common Stock - After market: 1.15 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 -0.08 -0.13 0.0536.08% Q1 2022 -0.16 -0.14 -0.02-14.26% Q4 2021 -0.13 -0.13 0.000.17% Q3 2021 -0.12 -0.10 -0.02-18.04% Q2 2021 -0.08 -0.12 0.0431.40% Q1 2021 0.22 0.00 0.224,365.55% Q4 2020 -0.11 -0.12 0.015.13% Q3 2020 -0.08 -0.12 0.0435.56%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.52 -0.11 -370.79%Q3 2022 -0.14 -0.12 -14.38%Q4 2022 -0.13 -0.13 0.69%FY 2023 -0.32 -0.52 38.15%Q1 2023 -0.04 -0.16 77.69%Q2 2023 -0.12 -0.08 -44.07%Q3 2023 -0.08 -0.14 45.01%Q4 2023 -0.04 -0.13 68.40%FY 2024 -0.16 -0.32 50.74%FY 2025 -0.22 -0.16 -41.62%FY 2026 -0.32 -0.22 -44.45%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 29.819M 24.128M 5.691M23.59% Q1 2022 16.735M 17.895M -1.16M-6.48% Q4 2021 20.409M 22.337M -1.928M-8.63% Q3 2021 21.543M 24.033M -2.49M-10.36% Q2 2021 26.266M 20.777M 5.489M26.42% Q1 2021 81.02M 31.672M 49.348M155.81% Q4 2020 18.45M 18.463M -13.428K-0.07% Q3 2020 18.39M 17.58M 809.617K4.61%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 95.235M 149.236M -36.19%Q3 2022 23.062M 21.543M 7.05%Q4 2022 23.42M 20.409M 14.75%FY 2023 126.619M 95.235M 32.95%Q1 2023 44.019M 16.735M 163.04%Q2 2023 27.044M 29.819M -9.31%Q3 2023 32.414M 23.062M 40.55%Q4 2023 37.771M 23.42M 61.28%FY 2024 153.521M 126.619M 21.25%FY 2025 191.3M 153.521M 24.61%FY 2026 243.143M 191.3M 27.10%